WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals”
“Partnerships, Licensing, Investments and M&A Deals and Trends for December 2017 in Pharmaceuticals”, report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in December 2017.
The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/3031250-partnerships-licensing-investments-and-m-a-deals-and
Major Highlight of the Report
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in December 2017. The industry reported 375 deals worth USD21 billion in December 2017, compared to 403 deals worth USD27.5 billion in November 2017. The oncology therapeutics market remained at the top in deal activity in December 2017 with 124 deals.
Pharmaceuticals Sector Investments and M&A Major Outlook
Analysis of the market trends for the pharmaceutical industry in the global arena.
Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women’s health segments.
Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
Analysis of partnership and licensing deals based on clinical stage of development of products.
Summary of the pharmaceutical deals globally in the six months.
Information on the top deals happened in the pharmaceutical industry.
Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Pharmaceuticals Sector Investments and M&A – Competitive Analysis
Key players are making innovative developments in Pharmaceuticals Sector Investments and M&A. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3031250-partnerships-licensing-investments-and-m-a-deals-and
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)